Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars U Fokdal

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|April 29, 2003
[Malignant insulinoma is a rare cause of hypoglycemia]Lars U Fokdal, Flemming Hansen
Ugeskrift for Laeger|September 15, 2005
[Late effects following curative radiotherapy for prostate cancer]Lars U Fokdal, Morten Høyer
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancerSandy Mohamed, Søren K Nielsen, Lars U Fokdal, et al.
Brachytherapy|September 2, 2014
Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancerSandy M I Mohamed, Torben Aagaard, Lars U Fokdal, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2019
Reporting of Late Morbidity After Radiation Therapy in Large Prospective Studies: A Descriptive Review of the Current StatusAnders S Vittrup, Kathrin Kirchheiner, Lars U Fokdal, et al.
Brachytherapy|December 23, 2014
Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator positionKaren S Nkiwane, Richard Pötter, Lars U Fokdal, et al.
Physics and Imaging in Radiation Oncology|January 18, 2021
Robustness of elective lymph node target coverage with shrinking Planning Target Volume margins in external beam radiotherapy of locally advanced cervical cancerThomas Berger, Lars U Fokdal, Marianne S Assenholt, et al.
Cancers|April 3, 2021
Image-Guided Adaptive Brachytherapy (IGABT) for Primary Vaginal Cancer: Results of the International Multicenter RetroEMBRAVE Cohort StudyHenrike Westerveld, Maximilian P Schmid, Remi A Nout, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2016
Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE studyRenaud Mazeron, Lars U Fokdal, Kathrin Kirchheiner, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I StudyNina B K Jensen, Richard Pötter, Sofia Spampinato, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|April 29, 2003
[Malignant insulinoma is a rare cause of hypoglycemia]Lars U Fokdal, Flemming Hansen
Ugeskrift for Laeger|September 15, 2005
[Late effects following curative radiotherapy for prostate cancer]Lars U Fokdal, Morten Høyer
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancerSandy Mohamed, Søren K Nielsen, Lars U Fokdal, et al.
Brachytherapy|September 2, 2014
Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancerSandy M I Mohamed, Torben Aagaard, Lars U Fokdal, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2019
Reporting of Late Morbidity After Radiation Therapy in Large Prospective Studies: A Descriptive Review of the Current StatusAnders S Vittrup, Kathrin Kirchheiner, Lars U Fokdal, et al.
Brachytherapy|December 23, 2014
Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator positionKaren S Nkiwane, Richard Pötter, Lars U Fokdal, et al.
Physics and Imaging in Radiation Oncology|January 18, 2021
Robustness of elective lymph node target coverage with shrinking Planning Target Volume margins in external beam radiotherapy of locally advanced cervical cancerThomas Berger, Lars U Fokdal, Marianne S Assenholt, et al.
Cancers|April 3, 2021
Image-Guided Adaptive Brachytherapy (IGABT) for Primary Vaginal Cancer: Results of the International Multicenter RetroEMBRAVE Cohort StudyHenrike Westerveld, Maximilian P Schmid, Remi A Nout, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2016
Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE studyRenaud Mazeron, Lars U Fokdal, Kathrin Kirchheiner, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I StudyNina B K Jensen, Richard Pötter, Sofia Spampinato, et al.
Pageof 2